MedPage Today on MSN
Autoimmune Anemia Is the Latest Condition Found Responsive to CAR-T Therapy
Eleven patients with refractory autoimmune hemolytic anemia (AIHA) were all brought into drug-free remission with CAR T-cell ...
The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...
Artiva Biotherapeutics is developing NK cell immunotherapy for autoimmune disease. Early trial data in B-cell lymphoma ...
Rockville, Maryland Friday, January 9, 2026, 10:00 Hrs [IST] ...
T-cell engagers (TCEs) have the most promising product profile across all deep B-cell depleting modalitiesCizutamig (BCMA TCE) positioned as first and best-in-class for autoimmune diseasesOver 60 ...
Kanazawa University, in collaboration with Osaka University and the National Institutes for Quantum Science and Technology, ...
The Immune Atlas identifies immune signatures in MM, enhancing outcome prediction and guiding personalized therapies by ...
5don MSN
Genetic risk factor and viral infection jointly contribute to multiple sclerosis, study suggests
Recent findings suggest that the Epstein-Barr virus (EBV) is involved in both causing multiple sclerosis (MS) and shaping its ...
FDA grants Breakthrough Therapy designation to ianalumab for Sjögren disease after the monoclonal antibody showed significant disease improvement.
Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback